A conversation about improving patient engagement in the pharmaceutical sector doesn't stop when a prescription is written. Patients still need to start their treatment, follow their care plan, and get the support they need along the way. That's pretty much the foundation of any pharma patient engagement strategy.
But knowing how to engage and when is only part of the job. You also need to know what to measure and how to choose a platform that can connect patient interactions to outcomes. Getting that right improves adherence and gives pharma companies better visibility into what happens after treatment begins.
Engaging patients at every step of their journey reduces the chance of them falling off track. That happens more commonly than most people assume. Around 125,000 deaths and 25% of hospitalizations are linked to non-adherence in the United States every year.
These are avoidable cases that became worse after a prescription was written, not because patients didn’t receive timely care. That critical window is where pharma patient engagement actually makes a big difference.
Cost is the first reason many patients drop off. Prescription abandonment remains under 5% when patients don't have to pay out of pocket. That percentage, however, climbs to 45% once the cost passes $125. The worse part here is that most patients actually qualify for copay, but they just don't know about their coverage plans. They'll abandon their medication, leaving it up to the pharmacy to intervene at the right moment to tell them they're covered.
The other gap is trust. Only about 18% of patients trust pharmaceutical companies, so every message a brand sends starts with a significant trust deficit. But this uphill battle is still winnable. One study found that a $100,000 investment into patient engagement could raise a drug's NPV by more than 500 times the spend.
It isn't that the pharmaceutical sector isn't trying to engage their patients. The cracks mostly appear due to fragmentation, meaning that their communications are split between multiple systems, each one operating in isolation.
There's no coordination at all, making a simple refill reminder more challenging than it should be. The patient engagement strategies below show how to remove those gaps.
Adding another channel won't fix a disconnected patient experience. When your channels operate in silos, another touchpoint just adds to the chaos.
Say a patient learns from a healthcare professional that their copay fully covers the first prescription refill. However, a week later, the patient receives an automated text about a pending prior authorization and that they might owe the full price. Now the patient doesn't know which message to trust, and they’ll likely just fall off track.
Building connected journeys starts by coordinating all existing channels, so that each one knows what the other has done. This visibility ensures accurate and relevant messaging for each patient across their journey.
The problem with campaign calendars is that they run on their own timelines. Someone who was just diagnosed might want to understand their condition better. Someone else who is three months into their care plan might want help managing side effects. Those are two different patients in two different moments in their journeys. An adherence email sent to the second patient may be relevant, but it can still miss the moment that matters most.
Hence, outreach should be based on the patient's events or milestones. That same adherence email carries more weight when it arrives after a patient misses their first refill, because the message responds to something that just happened rather than simply following a campaign schedule.
The last thing a patient needs is switching between portals, remembering their logins, and figuring out where to navigate to get what they need. Unfortunately, that's just how most patient engagement tools work in the pharmaceutical sector. Each one comes with a separate login for one service, and a phone number for another.
A single digital hub can bring all those pieces together in one place for the patient's convenience. Their experience and satisfaction levels naturally improve when they can check their prescription status, understand coverage and cost, apply for a new refill, learn about side effects, and more from a single screen.
For pharma teams evaluating the best patient engagement platforms, if the platform gives patients another login to remember, it hasn't really simplified the experience.
A pharma brand's outreach is severely limited without public trust. Patients are more likely to open up to someone who has already gone through the same treatment journey. That's where peer support can fill a gap brand messaging can't.
Someone who has lived through the early treatment stages can answer questions a campaign never could. They can share the challenges, doubts, and small lessons they wish someone had shared with them. That turns peer support from another brand message into a conversation with someone patients can relate to.
Pharma brands can bring this into their patient programs through trained mentors, moderated communities, or both. Those conversations still need structure, though, so mentors need training, defined boundaries, and a way to escalate safety concerns when something falls outside their role.
Every pharmacy's front-line team learns things from patient interactions that other teams don't. They hear about where prior authorizations are stalling, which questions keep coming up again and again, and when patients start struggling with treatment.
Medical Affairs can use that information to refine educational content. Commercial teams can see where patients or providers are running into friction. Without that connection, each team keeps working from its own view of the patient journey.
A patient engagement platform should make that information accessible across the organization instead of relying on quarterly reports.
Every interaction with a patient generates signals that pharma companies can use to improve their patient engagement strategy. However, when you have thousands of patients, even additional staff hiring can't keep up with that many signals every week.
That scalability problem is where AI helps. It automatically watches every interaction to log each signal, without burning out your staff.
You don't need a staff member to send every reminder or message. AI automatically does that by integrating with your existing patient records and firing off outreach as needed. That smart automation ensures your patients hear from you exactly when they most need to, while freeing your staff to handle more complex matters.
Timing is critical here, though. Even a personalized refill reminder won't work if it never gets read. AI uses historical data to build patient cycles. So it knows when someone is due for a monthly refill and can send out a nudge if they haven't yet sent in a request. This makes automated outreach part of the patient journey instead of just another scheduled campaign.
Patients can't be expected to follow your business hours. They might have an important question in the middle of the night or need a refill on a holiday. Conversational AI agents can answer those routine questions, while also acting as a self-service channel, 24/7.
If a prescription hasn't arrived, the AI can check the shipment status and tell the patient where it is instead of delivering a generic "it's on the way" response. The system can also activate a copay card or provide an update on a prior authorization.
Furthermore, AI chatbots can pull answers from approved knowledge bases to handle routine clinical questions. However, considering how pharmacy falls under a regulated industry, there need to be safeguards built in.
Just because an AI can't find an accurate answer doesn't mean it should make one up. Make sure to program the AI to escalate such cases to a qualified medical specialist on the team. This also highlights another core benefit of not burning out your medical professionals on routine questions.
Most adherence programs only learn about a patient after they've been off their meds for months. Even basic automated refill tools count how many months someone hasn't come in for a refill before sending an alert. AI catches such patients sooner.
A 2026 study shows how machine learning helped identify arthritis patients at higher risk of stopping treatment using information available when they first entered pharmacy services. The model looked for patterns in that information that were linked to early treatment discontinuation. In other words, the warning signs were there from day one, before the patient ever fell off track.
However, an early warning is only meaningful if someone acts upon it. That's why measuring patient engagement in pharma should go beyond counting messages or completed calls. Success should be tracked by the number of high-risk patients contacted within a week, and subsequently by how many of them remain on therapy six months later.
Sending the same message to every patient in a list actually hurts patient engagement. AI can track patients as they move through their care journey, gathering context to determine what they need in a given moment.
That might mean sending a refill reminder by text, following up with a phone call, or holding off until there's a reason to reach out. The point is to respond to the patient rather than the campaign calendar.
Another way to look at this is how traditional campaigns see pharmacies simply decide what message to send out this week. AI changes that to what "this" patient needs to hear from you right now.
The window between getting a prescription and the first dose is where most pharmacies lose their patients. Patients can still get stuck waiting for benefits checks, prior authorizations, paperwork, or a response from their pharmacy before treatment starts.
AI speeds that up by resolving what pharmacies are currently handling manually. The system can automatically check benefits, follow up on prior authorization status, and keep routine cases moving without requiring staff to make every call themselves. That gives your team more time to focus on cases that actually need human attention.
Patients also need to know what's happening while they wait. A message saying, “We're working on it,” doesn't give them much to go on. Telling them their prior authorization was submitted Tuesday and they'll get an update Thursday gives them a clear next step. That's a sign of a well-designed pharma patient engagement platform.
We're not ranking vendors here. When searching for the best AI patient engagement platforms for pharma, you'll likely notice that they all pretty much list the same features. So what are the criteria here? You need to test certain features like omnichannel capabilities and HIPAA compliance to confirm how they match against your existing systems.
The point of an engagement platform is to show you a patient's complete journey on a single screen. If your new platform doesn't connect your EHRs, CRMs, or any other tools you're using, it's just another screen your team has to switch between during live calls.
This increases the likelihood of missing important updates. For example, a patient's prior authorization might have been denied yesterday. But since the platform never got that update, it automatically texts the patient today that their refill is on the way.
That's why check your integrations first. Ask directly what level of information the platform can access from your CRMs or EHRs, and whether it’s read-only or the data flows both ways.
Most pharma companies have added new channels and engagement programs over time as needed. So even though a platform might be supporting three channels, each one operates in isolation.
Orchestration connects all interactions across all supported channels in one shared record. The system monitors where a patient is exactly in their journey and triggers only what's needed.
Let's say a patient was sent an automated text to apply for a refill. But they reply asking for a call instead because they have questions. Orchestration will understand what's needed and alert a pharmacist on your team to make the call, while pausing a promotional email sequence until the patient has resolved their refill problem.
Having a shared record also improves personalization. This goes beyond having a system that greets with first names. Since orchestration knows where a patient is in their journey, it uses that data to generate interactions that are actually relevant to the patient. Someone three months into a treatment program will appreciate educational content about side effects or alternative drugs. The same won't work on a patient who needs help with their first refill.
So ask the vendor to pull up one patient's full history across every channel on a single screen. Then ask what happens to scheduled messages when that patient replies on a different channel, and how the system can personalize interactions based on a patient's journey.
Let's start with consent. Your automated workflows still need to collect a patient's consent before sending them messages over each channel. This is mandated by TCPA and HIPAA as separate legal requirements for any pharma engagement platform, and it's non-negotiable.
If a patient has only consented to text messages, calling them can be seen as a violation. If they revoke their consent, the system should update itself immediately, regardless of which channel they used. That means a patient who calls your office to say they're opting out of texts is still valid under FCC laws, even though the request came through a phone call.
Next comes compliance. All patient communications need to be secure and encrypted during transit as well as storage. This is where it's important to find a vendor willing to sign a BAA. A vendor who refuses to sign an agreement is a vendor you can cross off your list. Make sure to also review their HITRUST certifications, and then ask the vendor to show how their system handles consent and PHI.
A platform that only tells you open rates isn't helpful in deciding what should happen next. That's because even a high open rate just confirms a patient saw your message. But did they act on it? Did they log into the portal? Was their prior authorization completed? The right patient engagement platform for pharma tracks these as well to improve your decision-making.
So ask the vendor whether their platform stops at campaign metrics or if it shows what patients are actually doing. Hub enrollment, time to therapy initiation, and prescription abandonment are some examples that show whether your programs are moving patients forward. Adherence is another important measure to track that confirms your engagement is working.
That's why your reporting needs to connect patient-level engagement data. It should show what your messages helped them accomplish.
KPIs are important, but only when they close the loop back to the patient. Just monitoring read or open rates doesn't tell much unless you're looking beyond into what a message helped a patient achieve.
An engagement strategy that's built only to get patients to respond won't tell you when they quietly drop off or, when they do, what your team should do next. That can happen when pharmacies are running separate programs for reminders, adherence, and other parts of the patient journey. While you can track each interaction, it's much harder to see what's happening between them, let alone act on it.
WestCX gives you that visibility while connecting communication and engagement across the channels and systems you already use. That's one, fully-integrated solution: tracking every patient journey and showing your team exactly how each one is moving, where they're getting stuck, and what they should do next.
WestCX Orchestrate™ takes that a step further by coordinating those interactions around the patient journey. It can automate routine conversations, carry context from one interaction to the next, and determine the next best step based on what the patient has done, or hasn't done.
Your automated systems might generate a missed refill reminder, but Orchestrate doesn't stop there. It can use the patient's response as a signal to trigger the next action. That could mean sending another reminder through a different channel or routing the patient to your team for a manual follow-up.
That gives you more to measure than the number of calls made or messages sent. You can see where patients disengage, how they move through your programs, and how those patterns relate to the outcomes you're trying to improve.
If you're looking to make patient engagement more connected, measurable, and responsive, schedule a demo with WestCX Orchestrate and see how our pharma solution can improve your existing workflows.